Literature DB >> 20392842

Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection.

R Anthony Barnitz1, Fengyi Wan, Vinay Tripuraneni, Diane L Bolton, Michael J Lenardo.   

Abstract

Infection with human immunodeficiency virus type 1 (HIV-1) causes an inexorable depletion of CD4(+) T cells. The loss of these cells is particularly pronounced in the mucosal immune system during acute infection, and the data suggest that direct viral cytopathicity is a major factor. Cell cycle arrest caused by the HIV-1 accessory protein Vpr is strongly correlated with virus-induced cell death, and phosphorylation of Vpr serine 79 (S79) is required to activate G(2)/M cell cycle blockade. However, the kinase responsible for phosphorylating Vpr remains unknown. Our bioinformatic analyses revealed that S79 is part of a putative phosphorylation site recognized by protein kinase A (PKA). We show here that PKA interacts with Vpr and directly phosphorylates S79. Inhibition of PKA activity during HIV-1 infection abrogates Vpr cell cycle arrest. These findings provide new insight into the signaling event that activates Vpr cell cycle arrest, ultimately leading to the death of infected T cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392842      PMCID: PMC2903295          DOI: 10.1128/JVI.02273-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  83 in total

Review 1.  Physiological substrates of cAMP-dependent protein kinase.

Authors:  J B Shabb
Journal:  Chem Rev       Date:  2001-08       Impact factor: 60.622

2.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

3.  Death of CD4(+) T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis.

Authors:  Diane L Bolton; Beom-Ik Hahn; Eugenia A Park; Laura L Lehnhoff; Felicita Hornung; Michael J Lenardo
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.

Authors:  F Re; D Braaten; E K Franke; J Luban
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat.

Authors:  L Wang; S Mukherjee; F Jia; O Narayan; L J Zhao
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

6.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Human immunodeficiency virus replication: modulation by cellular levels of cAMP.

Authors:  M A Nokta; R B Pollard
Journal:  AIDS Res Hum Retroviruses       Date:  1992-07       Impact factor: 2.205

8.  Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients.

Authors:  Daniela Mologni; Paola Citterio; Barbara Menzaghi; Barbara Zanone Poma; Chiara Riva; Valentina Broggini; Alessandro Sinicco; Laura Milazzo; Fulvio Adorni; Stefano Rusconi; Massimo Galli; Agostino Riva
Journal:  AIDS       Date:  2006-02-28       Impact factor: 4.177

9.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

10.  HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.

Authors:  Jean-Philippe Belzile; Ghislaine Duisit; Nicole Rougeau; Johanne Mercier; Andrés Finzi; Eric A Cohen
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823

View more
  18 in total

1.  Identification of an N-terminal truncation of the NF-κB p65 subunit that specifically modulates ribosomal protein S3-dependent NF-κB gene expression.

Authors:  Eric M Wier; Jordan Neighoff; Xin Sun; Kai Fu; Fengyi Wan
Journal:  J Biol Chem       Date:  2012-10-31       Impact factor: 5.157

2.  Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages.

Authors:  Sandra Söderholm; Denis E Kainov; Tiina Öhman; Oxana V Denisova; Bert Schepens; Evgeny Kulesskiy; Susumu Y Imanishi; Garry Corthals; Petteri Hintsanen; Tero Aittokallio; Xavier Saelens; Sampsa Matikainen; Tuula A Nyman
Journal:  Mol Cell Proteomics       Date:  2016-08-02       Impact factor: 5.911

3.  Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.

Authors:  Wen Xie; Denis Agniel; Andrey Shevchenko; Sergey V Malov; Anton Svitin; Nikolay Cherkasov; Marianna K Baum; Adriana Campa; Simani Gaseitsiwe; Hermann Bussmann; Joseph Makhema; Richard Marlink; Vladimir Novitsky; Tun-Hou Lee; Tianxi Cai; Stephen J O'Brien; M Essex
Journal:  AIDS Res Hum Retroviruses       Date:  2017-04-06       Impact factor: 2.205

4.  IKKβ phosphorylation regulates RPS3 nuclear translocation and NF-κB function during infection with Escherichia coli strain O157:H7.

Authors:  Fengyi Wan; Amanda Weaver; Xiaofei Gao; Michael Bern; Philip R Hardwidge; Michael J Lenardo
Journal:  Nat Immunol       Date:  2011-03-13       Impact factor: 25.606

5.  Human immunodeficiency virus type 1 Vif causes dysfunction of Cdk1 and CyclinB1: implications for cell cycle arrest.

Authors:  Keiko Sakai; R Anthony Barnitz; Benjamin Chaigne-Delalande; Nicolas Bidère; Michael J Lenardo
Journal:  Virol J       Date:  2011-05-11       Impact factor: 4.099

6.  Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell death.

Authors:  R Anthony Barnitz; Benjamin Chaigne-Delalande; Diane L Bolton; Michael J Lenardo
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

Review 7.  Cellular kinases incorporated into HIV-1 particles: passive or active passengers?

Authors:  Charline Giroud; Nathalie Chazal; Laurence Briant
Journal:  Retrovirology       Date:  2011-09-02       Impact factor: 4.602

8.  Avibirnavirus VP4 Protein Is a Phosphoprotein and Partially Contributes to the Cleavage of Intermediate Precursor VP4-VP3 Polyprotein.

Authors:  Sanying Wang; Boli Hu; Weiying Si; Lu Jia; Xiaojuan Zheng; Jiyong Zhou
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

9.  The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions.

Authors:  Ayumi Kudoh; Shoukichi Takahama; Tatsuya Sawasaki; Hirotaka Ode; Masaru Yokoyama; Akiko Okayama; Akiyo Ishikawa; Kei Miyakawa; Satoko Matsunaga; Hirokazu Kimura; Wataru Sugiura; Hironori Sato; Hisashi Hirano; Shigeo Ohno; Naoki Yamamoto; Akihide Ryo
Journal:  Retrovirology       Date:  2014-01-22       Impact factor: 4.602

10.  HIV-1-associated PKA acts as a cofactor for genome reverse transcription.

Authors:  Charline Giroud; Nathalie Chazal; Bernard Gay; Patrick Eldin; Sonia Brun; Laurence Briant
Journal:  Retrovirology       Date:  2013-12-17       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.